Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

H1N1 flu tests advance

This article was originally published in The Gray Sheet

Executive Summary

Quest Diagnostics debuts the Focus Diagnostics influenza A H1N1 RNA RT-PCR test as the first commercial laboratory testing service to aid in identification of previously named swine flu, the firm announces May 11. Expected turnaround time for results is within 24 hours of receipt of the specimen. Meanwhile, Osmetech on May 14 submits a request to FDA for emergency use authorization for its Respiratory Pathogen Test Panel as a screen for H1N1. And Roche says it is making available its research use detection kit for the influenza A/H1N1 virus, which can be run on its LightCycler 480 II, 2.0 and1.5 systems; the firm notes it is filing with health authorities worldwide to allow use in emergency situations. Officials say rapid testing tools are needed to help get a handle on the path of the disease (1"The Gray Sheet" May 4, 2009, p. 3)

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT027446

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel